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A B S T R A C T
The aim of the study was to compare the effect of sevoflurane and propofol anesthesia
on myocardial contractility during laparotomic cholecystectomy using transesophageal
echo-Doppler. In the study, 40 patients were randomized into two groups, depending on
whether they received sevoflurane or propofol anesthesia. Heart rate, cardiac index,
stroke volume, left ventricular ejection time and acceleration were measured 10 minutes
after induction of anesthesia, 1 minute and 25 minutes after incision. The results were
analyzed using paired t-test and ANOVA. Significantly lower values were found for all
parameters after the initial measurement (p<0.05). In the sevoflurane group, stroke vol-
ume decreased from 666.2 ml/beat to 656.4 ml/beat and to 635.6 ml/beat 1 minute
and 25 minutes after incision respectively. In the propofol group changes were from 64
ml/beat to 5810.5 ml/beat to 588.6 ml/beat. Stroke volume was significantly higher
in the sevoflurane than in the propofol group (p<0.05). Sevoflurane anesthesia allows a
better hemodynamic stability during laparotomic cholecystectomy.
Key words: sevoflurane, propofol, echocardiography, transesophageal,
hemodynamics, cholecystectomy
Introduction
Nowadays, an anesthesiologist can
use numerous intravenous or inhalation
anesthetics, which allow many combina-
tions and ways of usage. The introduction
of total intravenous anesthesia and the
use of volatile induction/maintenance an-
esthesia has led to the reintroduction of
»single-agent« anesthesia and the elimi-
nation of the transition phase between
the induction and the maintenance. The
advantages of total intravenous anesthe-
sia versus volatile induction/maintenan-
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ce anesthesia are still the subject of many
investigations, but, on the other hand,
the principle of »single-agent« anesthesia
in relation to balanced anesthesia is still
the subject of extensive investigations1,2.
Many studies have investigated the phar-
macokinetics and pharmacodynamics of
various anesthetic agents, but only a small
number of them have investigated anes-
thetic repercussions on myocardial con-
tractility3.
Sevoflurane was first described in
1972 and introduced in clinical use in Ja-
pan in 1990, in Germany in 1995 and in
the United States (USA) in 1996. Com-
pared with older inhalation agents, such
as desflurane or halothane, the most im-
portant property of sevoflurane is its low
blood/gas partition coefficient of 0.69, which
results in a rapid wash-in and wash-out.
Furthermore, sevoflurane depresses car-
diovascular function and myocardial con-
tractility, similarly to isoflurane, but less
than halothane and enflurane.
Modern principles of anesthesia have
made some new starting points in the an-
esthesiologist profession. A faster awak-
ening from general anesthesia, a better
control of anesthesia deepness and the
cost/benefit ratio are the advantages of
sevoflurane in comparison with intrave-
nous anesthesia, especially in short sur-
geries2.
There are still many controversies on
the impact of sevoflurane versus propofol
on cardiovascular stability. Some authors
have not found any differences between
sevoflurane and propofol2,4, whereas oth-
ers favor one anesthetic over the other be-
cause of their alleged good action on he-
modynamic stability5.
The aim of this study was to compare
the effect of sevoflurane and propofol on
myocardial contractility. The investiga-
ted drugs were administered using a non-
invasive technique of transesophageal echo




In a prospective randomized clinical
study, forty patients were monitored be-
tween April 10 and December 1, 2002.
The Hospital Ethical Committee had ap-
proved the study protocol. All the partici-
pants had been informed about the inves-
tigation and had signed the Informed Con-
sent before the surgery. Of forty patients
included in the study, 20 were randomly
assigned to the sevoflurane group: 10 male
and 10 female subjects, aged between 25
and 64 years (median value 45). Other 20
patients, 10 male and 10 female, aged be-
tween 35 and 62 (median value 49), for-
med the propofol group. Before the mea-
surements body surface area (BSA) was
calculated for each patient, and its me-
dian values were calculated for each group.
It was 1.9 m2 (1.7–2.3 m2) in the sevoflu-
rane group and 1.8 m2 (1.7–2.0 m2) in the
propofol group.
All the study subjects had to conform
to the following preoperative inclusion
criteria: a laparotomic cholecystectomy for
which general anesthesia and tracheal
intubation, not longer than one hour, were
indicated. Finally, all the patients were
classified using the ASA physical status
in the class I and class II.
The exclusion criteria were: any con-
firmed esophagus disease that could com-
promise the insertion of TEED (such as a
confirmed esophageal carcinoma, esopha-
gitis or dilated distal venous plexus of the
esophagus)6. Furthermore, excluded were
also all patients in whom preoperative
data on a suspected development of ma-
lignant hyperthermia on halogenated an-
esthetics in earlier anesthesias were un-
clear.
Anesthesia
All patients received premedication
half an hour before the surgery. As pre-
medication, midazolam (Dormicum®, F.
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Hoffman-La Roche Ltd., Basel, Switzer-
land), in an IM dose of 0.07–01 mg/kg was
prescribed. For the induction of anesthe-
sia, both patient groups received the
same protocol: propofol (Propofol®, Frese-
nius Kabi South Africa Ltd., Vorna Valley,
Midrand) 1–2 mg/kg IV, fentanyl (Fen-
tanyl®, Janssen Pharmaceutica, Beerse,
Belgium) 3–5 g/kg IV, and pancuronium
-bromide (Pavulon®, N. V. Organon, Oss,
the Netherlands) 0.08–0.12 mg/kg IV.
For the maintenance of anesthesia in
the sevoflurane group, 35% of O2 and 65%
of air were used, up to the total gas-flow
of 3 L/min and 1.5–3% of sevoflurane
(Sevorane®, Abbott Laboratories, S.A.,
Abbott Park, IL, USA) to achieve approxi-
mately 2.0% of the minimal alveolar con-
centration (MAC).
In the propofol group, patients recei-
ved a complete protocol of intravenous
maintenance of anesthesia. Anesthesia
was established by continuous infusion of
propofol in the dose of 100 g/kg/min, ac-
companied by usual doses of the 35% O2
and 65 % of air up to the total gas-flow of
3 L/min. If it was necessary, both groups
received bolus doses of fentanyl 2–3 g/kg
and 0.02 mg/kg of pancuronium-bromide.
Transesophageal echo-Doppler
Immediately after the induction of an-
esthesia, the transducer of TEED probe
HemoSonic™100 Hemodynamic Monitor
(Arrow International®) was inserted
through the mouth or the nose and posi-
tioned in the esophagus, at the approxi-
mate level of Th5-Th6 thoracic verte-
brae7. At this level, the aorta runs paral-
lel with the esophagus for about 5 cm and
the highest density of signal in TEED
probe can be achieved.
Before the insertion of the transeso-
phageal echo-Doppler transducer, a dis-
posable biocompatible sterile elastomer
sheath is mounted on it. The sheath is
filled with a sterile ultrasound gel that
ensures the transmission of ultrasound
waves without air interposition. The
transducer with the sheath is compressed
by the naturally contracting esophageal
wall, which immobilizes the transducer
in the esophagus, directing the ultrasound
sensors towards their aortic target8. The
transducer-sheath assembly can be used
with a naso-gastric tube inserted in situ,
without disturbing echo-Doppler sig-
nals9,10.
The cylindrical transducer handle can
rotate axially under external manual con-
trol. Finally, the transducer handle is se-
cured by a fixed arm attached to the oper-
ating table or bedside.
Hemodynamic monitoring
Hemodynamic parameters measured
were the following: heart rate (HR), car-
diac index (CI), stroke volume (SV), left
ventricular ejection time (LVET) and, fi-
nally, acceleration (Acc) as a sensitive in-
dicator of global LV performance and myo-
cardial contractility11. Acceleration mea-
sures the rate of change of blood velocity
just at the moment of the aortic valve
opening12,13. Mean arterial pressure (MAP)
was measured by means of a noninvasive
technique using the arm tourniquet cuff,
automatically cuffed every minute by the
pressure monitor device.
Measurements were performed three
times during anesthesia. The initial mea-
surement was performed 10 minutes af-
ter the induction of anesthesia. The sec-
ond measurement was performed 1 minu-
te after the incision and the final mea-
surement 25 minutes after the incision.
Statistics
Computational statistics was done us-
ing SPSS for Windows (release 7.5, SPSS
Inc., Chicago, IL, USA). Numerical data
were presented by means and standard
deviations. Initial measurements between
patient groups were compared using pai-
red t-test, while all measurements were
simultaneously compared using general
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linear model (GLM) analysis of variance
for repeated measurements (ANOVA).
Using this model, between- subject statis-
tics was accomplished to test the differ-
ence in parameter values between two
patient groups, while within-subject sta-
tistics was done to compare repeated
measurements. If the differences were
significant, initial parameter values were
compared with repeated measurements
(contrast). Both statistics obtained using
ANOVA were presented with the values
of F-distribution and probability p. In all
the tests only two-tailed p-values lower
than 0.05 were considered significant.
Results
In the initial measurement of hemody-
namic parameters there was no statisti-
cal significance between the patient groups
(Table 1).
The initial values of all measured he-
modynamic parameters were statistically
significantly higher in comparison with
the values estimated during the next two
measurements (Table 2, within-subject
effect, p<0.001 for all).
A statistically significant decrease of
HR was observed. In the sevoflurane
group, HR decreased from 75 beats/min
to 70 beats/min and to 69 beats/min re-
spectively (p=0.001) and in the propofol
group, a similar statistically significant
decrease in the HR was found – from 76
beats/min to 75 beats/min in both latter
measurements (p=0.001). Although all
three measurements showed lower val-
ues of HR in the sevoflurane group, these
values were not statistically significantly
different in comparison with HR values
in the propofol group (Table 2, p=0.090).
The values of CI, Acc and SV showed
the signs of myocardial depression in all
the estimated values, when compared
with the initial values of these parame-
ters in both groups of patients. Cardiac
index values decreased from 2.44 L/min/
m2 in the initial measurement, through
2.09 L/min/m2 to 2.08 L/min/m2 in the
propofol group. In the sevoflurane group,
CI decreased from 2.42 L/min/m2 in the
initial measurement to 2.21 L/min/m2, and
to 2.13 L/min/m2 respectively (Table 2).
The initial acceleration value in the
propofol group was 7.63 m/s2, and this
value decreased to 6.81 m/s2 and to 6.46
m/s2 over the measurements. The values
of acceleration in the sevoflurane group
changed from 7.38 m/s2 in the initial mea-
surement, through 6.92 m/s2, to 6.82 m/s2
(Table 2). Neither CI nor Acc showed sta-
tistically significant difference when com-
pared between two groups (p=0.348 for
CI, and p=0.780 for Acc), although the de-
crease of CI and Acc were strongly ex-
pressed in the propofol group.
In the sevoflurane group, stroke vol-
ume values were higher than in the pro-
pofol group. The measured values chan-
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TABLE 1
HEMODYNAMIC VALUES (MEAN  SD) AT INITIAL MEASUREMENT IN PATIENTS IN
SEVOFLURANE (N=20) AND PROPOFOL GROUP (N=20)
Hemodynamic parameters Patient groups Statistics





















































































































































































































































































































































































































































































































































































































































































































































































































ged from 66 ml/beat in the initial mea-
surement to 65 ml/beat and to 63 ml/beat
in the sevoflurane group at the end of the
measurement, while the values in the
propofol group decreased from 64 ml/beat
to 58 ml/beat for both measurements.
Stroke volume was statistically signifi-
cantly higher in the sevoflurane group in
comparison with the propofol group (be-
tween-subject effect; F = 4.26, p<0.05).
Finally, there was no statistical signif-
icance in the reduction of LVET values
between the groups. Lower values were
observed in the sevoflurane group (411
ms in the initial measurement, and re-
duced to 407 ms in both later measure-
ments) than in the propofol group, where
the initial value was 413 ms and de-
creased to 411 ms and to 407 ms respec-
tively (between-subject effect; F = 0.55, p
=0.464).
Discussion
In literature, there is a small number
of studies, which compare the influence of
sevoflurane and propofol on myocardial
contractility. Hemodynamic effects of se-
voflurane and propofol have been well
documented in animals14 and healthy hu-
mans, but not significantly higher values
of SV in sevoflurane anesthesia than in
propofol anesthesia. Statistical signifi-
cance was not noted in the increase of CI
in the sevoflurane group compared to the
propofol group. This observation could be
explained by the higher heart rate in the
sevoflurane group. A depressive anesthe-
tic action on myocardial function in the
present study was confirmed by the find-
ing of LVET and Acc reduction. These re-
ductions were strongly expressed in the
propofol group, but without statistical
significance when compared with the se-
voflurane group.
Regardless of a negative inotropic ef-
fect, in both patient groups there was no
registered significant hypotension (lower-
ing of the MAP for more than 20% in rela-
tion with the initial values), or need for
the drug treatment of hypotension.
The clinical implication of this obser-
vation, that propofol and sevoflurane im-
pair left ventricular inotropy, but impro-
ve myocardial function by Frank-Sterling
mechanism was corroborated in the pres-
ent investigation.
Similarly to the present results, Oz-
kose et al.4 reported bradycardia during
the use of sevoflurane and propofol in pa-
tients undergoing neurosurgical procedu-
res.
In contrast to Junckenhofel et al.1, our
results did not confirm a better hemo-
dynamic stability during propofol anes-
thesia, in comparison with sevoflurane,
or hypotension in either study group15.
Our findings of higher values of SV,
constant values of Acc and lower heart
rate with previously known cardioprotec-
tive effect on the myocardium16 in the
sevoflurane group suggest that sevoflu-
rane could be the anesthetic of choice in
abdominal surgery, especially in patients
with a previously known compromised
cardiovascular function17.
Thwaites et al.18 studied sevoflurane
and propofol as induction agents for the
day-case cystoscopy in 102 patients. In
contrast to the present study, these au-
thors had found an increase of HR with
each agent, but without significant differ-
ences between their groups. This finding
could be explained by the absence of ade-
quate premedication in their study. In-
creased HR values were also reported by
El-Orbany et al.19. An increase in HR or
the development of tachycardias during
anesthesia could be hemodynamically con-
siderable, because, they can produce myo-
cardial ischemia, especially in patients
with a previously compromised cardio-
vascular function20,21.
Inada et al.22 reported an increase in
heart rate, pulmonary capillary wedge
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pressure, mean pulmonary arterial pres-
sure and systemic vascular resistance, as
a response to the surgical incision at 1.5
MAC. Due to this, the authors concluded
that sevoflurane at 1.5 MAC could not
prevent the hemodynamic response to the
surgical incision.
On the other hand, sevoflurane, as an
inhalation anesthetic, has a different phar-
macodynamic effect from intravenous an-
esthetics. In contrast to intravenous an-
esthetics, sevoflurane advantages lie in
the induction to anesthesia, awakening
prudence, maintenance of anesthesia and,
finally, a lower price compared with other
anesthetics18. All these reasons make
sevoflurane one of good alternatives and
substitutions for propofol.
The limitation of this study is that
could not be possible to perform exact es-
timation of patients' response on incision.
Both effects of incision and anesthetics,
for now, it is not possible to clearly sepa-
rate. This part will be of interest for fur-
ther investigations. Further limitations
of this study were a small number of pa-
tients and, because of the type of surgical
procedure, a specific patient population.
In conclusion, sevoflurane ensures a
better patient hemodynamic stability in
comparison with propofol during laparo-
tomic cholecystectomy.
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HEMODINAMSKE RAZLIKE SEVOFLURANSKE I
PROPOFOLSKE ANESTEZIJE
S A @ E T A K
Cilj ispitivanja bio je usporediti u~inak sevofluranske i propofolske anestezije na
kontraktilitet miokarda tijekom kolecistektomije pomo}u transezofagusnog eho-Dople-
ra. U ovome ispitivanju 40 bolesnika randomizirano je prema vrsti anestezije na sevo-
fluransku i propofolsku skupinu. Hemodinamski parametri: frekvencija srca, indeks
srca, udarni volumen, izba~ajno vrijeme lijevoga ventrikula i akceleracija izmjereni su
10 minuta nakon indukcije anestezije, 1 minuta i 25 minuta nakon incizije. Rezultati
su analizirani parnim t-testom i analizom varijance. Znakovito su sni`ene sve vrijed-
nosti hemodinamskih parametara unutar obiju skupina bolesnika izmjerene 1 minuta
i 25 minuta nakon incizije (p<0.05). U sevofluranskoj skupini udarni volumen smanjio
se sa 666.2 mL/udarac na 656.4 mL/udarac i 635.6 mL/udarac nakon 1 minute i 25
minuta nakon incizije. U propofolskoj skupini udarni volumen smanjio se sa 648.9
mL/udarac na 5810.5 mL/udarac i 588.6 mL/udarac. Udarni volumen bio je znako-
vito ve}i u sevofluranskoj nego u propofolskoj skupini (p<0.05). Sevofluranska aneste-
zija osigurava bolju hemodinamsku stabilnost tijekom kolecistektomije.
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